- Trust is infrastructure. And Africa’s fintech reckoning proves it - Salvador Anglada, Optasia Group CEO
- Africa’s cement industry and the push for energy security - Krzysztof Lokaj, Wärtsilä Energy Africa Development Manager
- The 2026 Budget doubled your single discretionary allowance - Harry Scherzer, CEO, Future Forex
- Exclusive Convo: Nafissatou Fall Diagne, Managing Director, Development Finance Advisory
- Exclusive Interview: Sotiguy Coulibaly, Chief Executive Officer, KERALES FINANCE
This Tiny U.K. Drugmaker Has Soared More Than 800% in Stock Rout
LONDON (Capital Markets in Africa) — As the world scrambles to fight the deadly coronavirus, a microcap U.K. pharmaceutical company has seen its stock surge. Shares in Synairgen Plc have soared 845% this year, with gains accelerating in mid-March after the company got approval from U.K. regulators to start trials of its drug, SNG001, in people hospitalized with Covid-19. The company has a market capitalization of just 67 million pounds ($83 million), even after the share-price jump….
Read More







